Sugammadex and the Risk of Unintended Pregnancy in Women With Vascular Anomalies, An Alert for the Team

Key Points

• The research aims to address the interaction between sugammadex and hormonal contraceptives in women with vascular anomalies.
• Review of clinical data regarding sugammadex and hormonal contraceptive use.
• Discussion of risks associated with teratogenic therapies like sirolimus and thalidomide.
• Assessment of anesthesia practices in women with vascular anomalies.
• Identified potential for decreased contraceptive efficacy due to sugammadex.
• Emphasized the importance of awareness among healthcare teams regarding contraceptive management.
• Highlighted the need for further research into the interactions of anesthesia medications and hormonal contraceptives.

Abstract